vimarsana.com
Home
Live Updates
FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue : vimarsana.com
FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue
/PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific's Oncomine Dx Target Test as a companion...
Related Keywords
Japan
,
South Korea
,
Singapore
,
Garret Hampton
,
J Thorac Oncolo
,
Mauricio Minotta
,
Unity Lab Services
,
Japan Ministry Of Health
,
Janssen Biotech Inc
,
Thermo Fisher Scientific Inc
,
Fisher Scientific
,
Drug Administration
,
Our Mission
,
Thermo Fisher Scientific
,
Oncomine Dx Target Test
,
Janssen Biotech
,
Thermo Fisher
,
Fisher Oncomine Dx Target Test
,
Middle East
,
Thermo Scientific
,
Applied Biosystems
,
Important Safety Information
,
International Association
,
Lung Cancer
,
Lung Cancer Singapore
,
Worldwide Virtual
,
Contact Information
,
Heady Phone
,
vimarsana.com © 2020. All Rights Reserved.